Irani Zackary S.
Transaction: 08/26/2026
BUY
Change
+31,250
Price
$1.60
Filing
08/27/2026
Type
BUY
Biomerica, Inc.
BMRA • Medical - Devices
$2.31
▲ +0.09 (+4.05%)
Current price
EarningsLatest report: May 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$6.95M
Growth
2.4%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.72Healthy liquidity · 1.62Negative growth trendWeak profitability
Financial data as of: May 31, 2026, 12:00 AM UTCLast earnings update: May 31, 2026, 12:00 AM UTCLast profile update: Sep 2, 2026, 12:16 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.31
Change4.05%
Shares Out3.01M
Market Cap$6.95M
Enterprise Value$7.53M
52W Range1.45 - 3.22
Beta0.31
P/E-1.67
P/S1.61
P/B2.64
P/FCF-2.01
EV/Sales1.74
Price$2.31
Change4.05%
Shares Out3.01M
Market Cap$6.95M
Enterprise Value$7.53M
52W Range1.45 - 3.22
Beta0.31
P/E-1.67
P/S1.61
P/B2.64
P/FCF-2.01
EV/Sales1.74
EV/EBITDA-1.95
EV/FCF-2.18
Earnings Yield-60.02%
FCF Yield-49.73%
Dividend Yield0.00%
Gross Margin8.13%
Oper. Margin-119.47%
Profit Margin-84.77%
Debt/Eq0.72
Current Ratio1.62
Quick Ratio0.93
Revenue 5Y2.40%
Volume34.36K
Avg Volume51.02K
EPS Surprise0.76
Investment DNA
How strong this company looks for long-term investors
40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
60/100
Growth Potential
Revenue and expansion
26/100
Price Attractiveness
Cheap or expensive today
86/100
Why this score▼
Manageable debt level · 0.72Healthy liquidity · 1.62Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 3 analyst votes · 2026-09-05
100/100
Bullish
Bullish
3
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
BARBIERI ALLEN
Transaction: 08/26/2026
BUY
Change
+20,000
Price
$1.60
Filing
08/27/2026
Type
BUY
Chin Eric
Transaction: 08/26/2026
BUY
Change
+6,250
Price
$1.60
Filing
08/27/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Irani Zackary S. | BUY | +31,250 | $1.60 | 08/26/2026 | 08/27/2026 |
| BARBIERI ALLEN | BUY | +20,000 | $1.60 | 08/26/2026 | 08/27/2026 |
| Chin Eric | BUY | +6,250 | $1.60 | 08/26/2026 | 08/27/2026 |
| MOATAZEDI DAVID | BUY | +10,000 | $1.60 | 08/26/2026 | 08/27/2026 |
| Gary M. Huff | BUY | +31,250 | $1.60 | 08/20/2026 | 08/27/2026 |
| Chin Eric | BUY | +22,500 | Not reported | 12/12/2025 | 01/28/2026 |
| Gary M. Huff | BUY | +20,000 | Not reported | 12/12/2025 | 12/31/2025 |
| MOATAZEDI DAVID | BUY | +20,000 | Not reported | 12/12/2025 | 12/31/2025 |
| BARBIERI ALLEN | BUY | +30,000 | Not reported | 12/12/2025 | 12/31/2025 |
| Irani Zackary S. | BUY | +52,500 | Not reported | 12/12/2025 | 12/31/2025 |
| Lu Gary | BUY | +40,000 | Not reported | 12/12/2025 | 12/31/2025 |
| Chin Eric | OTHER | 0 | Not reported | 06/04/2025 | 06/06/2025 |
| Coste Catherine | BUY | +85,000 | $0.31 | 12/13/2024 | 12/17/2024 |
| Lu Gary | BUY | +155,000 | $0.31 | 12/13/2024 | 12/17/2024 |
| MOATAZEDI DAVID | BUY | +85,000 | $0.31 | 12/13/2024 | 12/17/2024 |
| BARBIERI ALLEN | BUY | +110,000 | $0.31 | 12/13/2024 | 12/17/2024 |
| Irani Zackary S. | BUY | +250,000 | $0.31 | 12/13/2024 | 12/17/2024 |
| Emerson Jane | BUY | +85,000 | $0.31 | 12/13/2024 | 12/17/2024 |
| BARBIERI ALLEN | OTHER | 0 | Not reported | 05/31/2024 | 07/03/2024 |
| Irani Zackary S. | BUY | +155,000 | $1.01 | 12/13/2023 | 12/14/2023 |